Status:
COMPLETED
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
Lead Sponsor:
University Hospital, Lille
Conditions:
Infection Viral
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
There is no predictive tool for patients admitted to the emergency department with a suspicion of Covid-19 that will worsen secondarily and require a heavy lifting. In a context of saturation of the ...
Eligibility Criteria
Inclusion
- Clinical criteria for suspicion of Covid-19 in an epidemic period
- Consultation in the emergency departement
- Non-opposition agree
Exclusion
- impairment related to another identified cause than Covid-19, in particular a rapid diagnostic test flu-positive
- Severe patient from the outset with transfer to intensive care within 12 hours of admission to the Emergency Department
- No social security coverage (beneficiary or entitled person)
- Poor understanding of French
- Refusal to participate
Key Trial Info
Start Date :
April 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 12 2020
Estimated Enrollment :
373 Patients enrolled
Trial Details
Trial ID
NCT04341792
Start Date
April 11 2020
End Date
November 12 2020
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Roger Salengro, CHU Lille
Lille, France, 59037